A synthetic lethal screen identifies HDAC4 as a potential target in MELK overexpressing cancers.
Zhou L, Zheng S, Rosas Bringas FR, Bakker B, Simon JE, Bakker PL, Kazemier HG, Schubert M, Roorda M, van Vugt MATM, Chang M, Foijer F.
Zhou L, et al.
G3 (Bethesda). 2021 Dec 8;11(12):jkab335. doi: 10.1093/g3journal/jkab335.
G3 (Bethesda). 2021.
PMID: 34550356
Free PMC article.